Answers are grounded in this paper and cite their sources.
Evidence-based CMGs are required to ensure the best clinical care for people with FRDA. Adopting the GRADE rare-disease framework enabled the development of higher quality CMGs for FRDA and allows individual topics to be updated as new evidence emerges. While the primary goal of these guidelines is better outcomes for people living with FRDA, the process of developing the guidelines may also help inform the development of clinical guidelines in other rare diseases.
No takes yet. Share an insight, caveat, or question.
Corben et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: